Section 5-304 - [See Note] Authorized providersNOT IN EFFECT** CONTINGENCY - NOT IN EFFECT - CHAPTER 147 OF 2016 **
// EFFECTIVE UNTIL JUNE 30, 2022 PER CHAPTER 147 OF 2016 //
(a) If an authorized provider is authorized to dispense or conduct research under State law, the Department shall register the authorized provider to dispense a controlled dangerous substance or to conduct research with a controlled dangerous substance listed in Schedule II through Schedule V.(b) An authorized provider who prescribes a controlled dangerous substance listed in Schedule II through Schedule V shall be registered with the Prescription Drug Monitoring Program described in Title 21, Subtitle 2A of the Health - General Article before obtaining a new or renewal registration with the Department under subsection (a) of this section.(c) The Department need not require separate registration under this section for an authorized provider who is:(1) engaged in research with a nonnarcotic controlled dangerous substance in Schedule II through Schedule V; and(2) already registered under this subtitle in another capacity.(d) An authorized provider may conduct research in the State with a controlled dangerous substance listed in Schedule I if the authorized provider is registered under federal law to conduct research with a controlled dangerous substance listed in Schedule I and gives evidence of the registration to the Department.Amended by 2016 Md. Laws, Ch. 147, Sec. 1, eff. upon the contingency stated in 2016 Md. Laws, Ch. 147 Sec. 8.This section is set out more than once due to postponed, multiple, or conflicting amendments.